Global Fund Board
The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria announced its approval of funding of up to $53.3 million for three interim applicants in the transition phase of the new funding model (NFM) on 23 December.
In approving the funding, the Board was acting on recommendations from the Technical Review Panel (TRP) and the Secretariat, including the Grant Approvals Committee (GAC).
On 7–8 November 2013, the Global Fund Board held its 30th meeting in Geneva, Switzerland. GFO was present, with observer status. The main decisions made at the meeting, in chronological order, were as follows. (For precise wording of what the Board agreed, see the decision points document that has been posted here.
Following extensive consultations with Board committees and donor and implementer constituencies, the Global Board has approved a revised Corporate KPI Framework. The framework is designed to present indicators to measure the goals, targets and objectives of the Global Fund’s Strategy for 2012–2016.
On 18–19 June 2013, the Global Fund Board held its 29th meeting in Colombo, Sri Lanka. GFO was present, with observer status. The main decisions made at the meeting, in chronological order, were as follows. (For precise wording of what the Board agreed, see the decision points document that has been posted here.
The Global Fund Board has appointed Martin O’Malley to serve as its next Inspector General, a position that requires him to lead the Office of the Inspector General (OIG). The appointment was necessary after the previous Inspector General had his appointment terminated by the Board in November 2012.
A draft of a new Corporate Key Performance Indicator (KPI) Framework 2013–2016 was presented to the Global Fund Board for review and discussion at the 29th Board meeting just concluded in Sri Lanka.
In what it describes as a “sea-change,” the Office of the Inspector General (OIG) said that it is moving away from its historical emphasis on country level grants towards “consulting engagements” focusing more on reviewing internal Secretariat processes and the work of other assurance providers.
The people involved in the Global Fund, and in global health generally, “are at an historic moment when the confluence of scientific advancement, epidemiological intelligence and experience from more than a decade of implementation come together to offer the opportunity to end three plagues as public health threats.”
Executive Director Mark Dybul’s first formal report to the Global Fund Board covered a lot of ground.
Gabriel Jaramillo, who was a member of the High-Level Panel and who served as the Global Fund’s General Manager from February 2012 to January 2013, has provided the Board with some reflections on his time working with the Fund.